Eli Lilly is a pharmaceutical company that has recently ventured into space-based research, partnering with companies like Redwire to explore drug manufacturing in microgravity. They are conducting experiments on the International Space Station (ISS) using Redwire's PIL-BOX platform to study the crystallization of pharmaceuticals, with the goal of improving drug discovery and development for diseases like diabetes and other chronic conditions. These experiments aim to leverage the unique microgravity environment to grow more uniform crystals, potentially leading to more effective treatments. Eli Lilly collaborates with organizations like Redwire, NASA, and the ISS National Lab to advance its space-based pharmaceutical research.
All verified mentions of this organization in source documents.
Ken Savin spent two decades at Eli Lilly.
Redwire supports partners including Aspera Biomedicines, Bristol Myers Squibb, Eli Lilly and Company, ExesaLibero Pharma, Purdue University, and Butler University.
The returned samples include crystals being studied by Eli Lilly and Company using Redwire’s PIL-BOX platform.
Redwire and Eli Lilly launched a research investigation in November 2023 that demonstrated insulin crystals grown in microgravity are larger and more ordered than those grown on Earth.
Redwire partnered with Eli Lilly and Company for a second spaceflight investigation that launched in March 2024.
Redwire’s PIL-BOX investigations with Eli Lilly and Butler University aim to produce results that could lead to improved therapeutics to treat an array of conditions.
Redwire Corporation is partnering with Eli Lilly and Company and Butler University for two investigations using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX).
Redwire is partnering with Eli Lilly and Company on a second spaceflight mission using the PIL-BOX pharmaceutical in-space laboratory.
Eli Lilly & Company conducted research and development on the International Space Station in 2023.
Redwire Corporation is partnering with Eli Lilly & Company to test the Pharmaceutical In-space Laboratory through a series of experiments aimed at improving drug discovery and development.
Eli Lilly and Company is partnering with Redwire on the PIL-BOX-01 mission to conduct three experiments focused on developing treatments for diabetes, cardiovascular disease, and pain.